Atopic dermatitis has a significant impact on the quality of life of patients, particularly with regards to burden of itch and sleep loss. Using diagnostic criteria to identify patients with atopic dermatitis is critical, as is utilizing disease severity assessment tools such as the Patient-Oriented Eczema Measure (POEM). These tools can help improve diagnostic accuracy, evaluate disease severity, and monitor response to treatment. Documentation of these assessments is also becoming increasingly necessary in order to help demonstrate the value of high-cost interventions. We invite you to participate in a quality improvement initiative with 10 of your patients who have atopic dermatitis, where you will document aspects of disease related to AD using diagnostic assessments, POEM, and the Hospital Anxiety and Depression Scale (HADS). Once you complete the follow-up survey and enter the chart data, you will be paid an honorarium of $400.

Zelma C. Chiesa Fuxench, MD, MSCE
Assistant Professor
Department of Dermatology
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

Step 1: Register for Quality Improvement Initiative here
Step 2: If you have not participated in the interactive educational webcast on atopic dermatitis, you can watch it here.
Step 3: Download the tools
Step 4: Use the tools to diagnose atopic dermatitis, assess disease severity, and monitor response to treatment. Document your findings in 10 patient charts. The tools can be printed and scanned into the patients’ charts.
Step 5: Enter the quantitative data from 10 of your patients’ charts and complete the follow-up survey here
Once you complete the follow-up survey, you will be paid an honorarium of $400
Registration will close once 30 participants have registered. Don’t wait!